Juan Moller San Pedro Claus
Insider CIK 1753222 · YMAB Director and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-12-14 | 2021-12-16 | 230,000 | — | $0 | 230,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-12-15 | 2020-12-16 | 226,800 | — | $0 | 226,800 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-03 | 2020-12-04 | 9,266 | $50.98 | $472.4K | 607,303 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 40,734 | $51.27 | $2.09M | 616,569 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-14 | 2020-05-15 | 139,154 | $36.02 | $5.01M | 657,303 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-13 | 2020-05-15 | 60,846 | $37.75 | $2.30M | 796,457 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2020-03-17 | 2020-03-19 | 1,900 | $17.22 | $32.7K | 1,900 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-01-07 | 2020-01-09 | 275,000 | — | $0 | 275,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2018-12-11 | 2018-12-13 | 211,500 | — | $0 | 211,500 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2018-09-25 | 2018-09-25 | 15,625 | $16.00 | $250.0K | 872,928 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2018-09-25 | 2018-09-25 | 15,625 | $16.00 | $250.0K | 872,928 | SEC↗ |